NCT02699281View on ClinicalTrials.gov

Efficacy of Ultra-micronized Palmitoylethanolamide (Um-PEA) in Geriatric Patients With Chronic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Chronic Pain
Interventions
DRUG

ultra-micronized palmitoylethanolamide

ultra-micronized palmitoylethanolamide 600 mg twice a day

DRUG

Placebo

um-PEA like placebo twice a day

Trial Locations (1)

20122

Geriatric Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan

All Listed Sponsors
lead

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

NCT02699281 - Efficacy of Ultra-micronized Palmitoylethanolamide (Um-PEA) in Geriatric Patients With Chronic Pain | Biotech Hunter | Biotech Hunter